How does AI for diabetic retinopathy detection integrate into patient care?
Discover the strategic rationale behind OSF HealthCare’s adoption and successful integration of LumineticsCore®, the first FDA-cleared autonomous AI system for diabetic retinopathy detection.
Dr. Mark Meeker, OSF’s Vice President and Chief Medical Officer, will share the strategy behind adopting LumineticsCore and Heidi Schlueter, a nursing and quality improvement leader, will walk through the operational details that made integration successful, from workflow design to staff engagement. Dena Weitzman, Sr. Director of Medical Affairs at Digital Diagnostics, will provide clinical context and moderate a practical discussion on how this technology is enhancing clinical workflows across diverse care settings.
This webinar will focus on how @OSF HealthCare:
- Selected LumineticsCore based on strategic goals
- Designed a successful workflow and drove staff engagement
- Addressed a critical care gap for diabetes-related eye care using AI
Participants will also gain insights into best practices for using AI in their own clinical workflows.
This session is designed for healthcare professionals eager to drive better patient care and enhance their clinical outcomes – right at the point-of-care. Secure your spot now!